Abstract
Purpose
We aimed to differentiate serous borderline ovarian tumors (SBOT) from serous epithelial ovarian carcinomas (SEOC) using morphological and functional MRI findings, to improve the patient management.
Method
We retrospectively investigated 24 ovarian lesions diagnosed with SBOT and 64 ovarian lesions diagnosed with SEOC. Additional to the demographic and morphological findings T2W signal intensity ratio, mean apparent diffusion coefficient (ADCmean) and total apparent diffusion coefficient (ADCtotal) values were analyzed and compared between two groups.
Results
Bilaterality, pelvic free fluid presence, serum CA-125 level (U/mL), presence of pelvic peritoneal implant were in favor of SEOC. Lower maximum size of solid component and solid size to maximum size ratio, dominantly cystic and solid-cystic appearance, exophytic growth pattern, presence of papiller projection and papillary architecture and internal branching pattern, higher T2W signal intensity ratio, ADCmean and ADCtotal values were in favor of SBOT.
Conclusion
Our study revealed that morphological and functional imaging findings were valuable in differentiating BSOT from SEOC.
Similar content being viewed by others
References
Zhao SH, Qiang JW, Zhang GF, Boyko OB, Wang SJ, Cai SQ, Wang L (2014) MRI appearances of ovarian serous borderline tumor: pathological correlation. J Magn Reson Imaging. 40:151-6. doi: https://doi.org/10.1002/jmri.24339
Li Y, Jian J, Pickhardt PJ, Ma F, Xia W, Li H, Zhang R, Zhao S, Cai S, Zhao X, Zhang J, Zhang G, Jiang J, Zhang Y, Wang K, Lin G, Feng F, Lu J, Deng L, Wu X, Qiang J, Gao X (2020) MRI-Based Machine Learning for Differentiating Borderline From Malignant Epithelial Ovarian Tumors: A Multicenter Study. J Magn Reson Imaging. 52:897-904
Kawaguchi, M., Kato, H., Hatano, Y., Tomita, H., Hara, A., Suzui, N., Miyazaki, T., Furui, T., Morishige, K. I., & Matsuo, M. (2020). MR imaging findings of low-grade serous carcinoma of the ovary: comparison with serous borderline tumor. Japanese journal of radiology, 38(8), 782–789. https://doi.org/10.1007/s11604-020-00960-2
Hu, J., Wang, Z., Zuo, R., Zheng, C., Lu, B., Cheng, X., Lu, W., Zhao, C., Liu, P., & Lu, Y. (2022). Development of survival predictors for high-grade serous ovarian cancer based on stable radiomic features from computed tomography images. iScience, 25(7), 104628. https://doi.org/10.1016/j.isci.2022.104628
Denewar, F. A., Takeuchi, M., Urano, M., Kamishima, Y., Kawai, T., Takahashi, N., Takeuchi, M., Kobayashi, S., Honda, J., & Shibamoto, Y. (2017). Multiparametric MRI for differentiation of borderline ovarian tumors from stage I malignant epithelial ovarian tumors using multivariate logistic regression analysis. European journal of radiology, 91, 116–123. https://doi.org/10.1016/j.ejrad.2017.04.001
Li, H. M., Zhao, S. H., Qiang, J. W., Zhang, G. F., Feng, F., Ma, F. H., Li, Y. A., & Gu, W. Y. (2017). Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki-67 expression. Journal of magnetic resonance imaging : JMRI, 46(5), 1499–1506. https://doi.org/10.1002/jmri.25696
Yang, S., Tang, H., Xiao, F., Zhu, J., Hua, T., & Tang, G. (2020). Differentiation of borderline tumors from type I ovarian epithelial cancers on CT and MR imaging. Abdominal radiology (New York), 45(10), 3230–3238. https://doi.org/10.1007/s00261-020-02467-w
Gershenson D. M. (2017). Management of borderline ovarian tumours. Best practice & research. Clinical obstetrics & gynaecology, 41, 49–59. https://doi.org/10.1016/j.bpobgyn.2016.09.012
Chen, J., Chang, C., Huang, H. C., Chung, Y. C., Huang, H. J., Liou, W. S., Chiang, A. J., & Teng, N. N. (2015). Differentiating between borderline and invasive malignancies in ovarian tumors using a multivariate logistic regression model. Taiwanese journal of obstetrics & gynecology, 54(4), 398–402. https://doi.org/10.1016/j.tjog.2014.02.004
deSouza, N. M., O'Neill, R, McIndoe, G. A., Dina, R., & Soutter, W. P. (2005). Borderline tumors of the ovary: CT and MRI features and tumor markers in differentiation from stage I disease. AJR. American journal of roentgenology, 184(3), 999–1003. https://doi.org/10.2214/ajr.184.3.01840999
Nougaret, S., Lakhman, Y., Molinari, N., Feier, D., Scelzo, C., Vargas, H. A., Sosa, R. E., Hricak, H., Soslow, R. A., Grisham, R. N., & Sala, E. (2018). CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas. AJR. American journal of roentgenology, 210(4), 918–926. https://doi.org/10.2214/AJR.17.18254
Li, Y. A., Qiang, J. W., Ma, F. H., Li, H. M., & Zhao, S. H. (2018). MRI features and score for differentiating borderline from malignant epithelial ovarian tumors. European journal of radiology, 98, 136–142. https://doi.org/10.1016/j.ejrad.2017.11.014
Zhang, Y., Tan, J., Wang, J., Ai, C., Jin, Y., Wang, H., Li, M., Zhang, H., & Zhong, S. (2021). Are CT and MRI useful tools to distinguish between micropapillary type and typical type of ovarian serous borderline tumors?. Abdominal radiology (New York), 46(7), 3354–3364. https://doi.org/10.1007/s00261-021-03000-3
Sahin, H., Akdogan, A. I., Smith, J., Zawaideh, J. P., & Addley, H. (2021). Serous borderline ovarian tumours: an extensive review on MR imaging features. The British journal of radiology, 94(1125), 20210116. https://doi.org/10.1259/bjr.20210116
Prat J. (2017). Pathology of borderline and invasive cancers. Best practice & research. Clinical obstetrics & gynaecology, 41, 15–30. https://doi.org/10.1016/j.bpobgyn.2016.08.007
Tanaka, Y. O., Okada, S., Satoh, T., Matsumoto, K., Oki, A., Nishida, M., Yoshikawa, H., Saida, T., & Minami, M. (2011). Ovarian serous surface papillary borderline tumors form sea anemone-like masses. Journal of magnetic resonance imaging : JMRI, 33(3), 633–640. https://doi.org/10.1002/jmri.22430
Park, S. B., Kim, M. J., Lee, K. H., & Ko, Y. (2018). Ovarian serous surface papillary borderline tumor: characteristic imaging features with clinicopathological correlation. The British journal of radiology, 91(1088), 20170689. https://doi.org/10.1259/bjr.20170689
Jang, Y. J., Kim, J. K., Park, S. B., & Cho, K. S. (2007). Variable CT findings of epithelial origin ovarian carcinoma according to the degree of histologic differentiation. Korean journal of radiology, 8(2), 120–126. https://doi.org/10.3348/kjr.2007.8.2.120
Mimura, R., Kato, F., Tha, K. K., Kudo, K., Konno, Y., Oyama-Manabe, N., Kato, T., Watari, H., Sakuragi, N., & Shirato, H. (2016). Comparison between borderline ovarian tumors and carcinomas using semi-automated histogram analysis of diffusion-weighted imaging: focusing on solid components. Japanese journal of radiology, 34(3), 229–237. https://doi.org/10.1007/s11604-016-0518-6
Zhao, S. H., Qiang, J. W., Zhang, G. F., Ma, F. H., Cai, S. Q., Li, H. M., & Wang, L. (2014). Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation. European radiology, 24(9), 2292–2299. https://doi.org/10.1007/s00330-014-3236-4
Pi, S., Cao, R., Qiang, J. W., & Guo, Y. H. (2018). Utility of DWI with quantitative ADC values in ovarian tumors: a meta-analysis of diagnostic test performance. Acta radiologica (Stockholm, Sweden : 1987), 59(11), 1386–1394. https://doi.org/10.1177/0284185118759708
Ma, F. H., Li, Y. A., Liu, J., Li, H. M., Zhang, G. F., & Qiang, J. W. (2019). Role of proton MR spectroscopy in the differentiation of borderline from malignant epithelial ovarian tumors: A preliminary study. Journal of magnetic resonance imaging : JMRI, 49(6), 1684–1693. https://doi.org/10.1002/jmri.26541
Thomassin-Naggara, I., Daraï, E., Cuenod, C. A., Rouzier, R., Callard, P., & Bazot, M. (2008). Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. Journal of magnetic resonance imaging : JMRI, 28(1), 111–120. https://doi.org/10.1002/jmri.21377
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant fnancial or nonfnancial interests to disclose.
Ethical approval
This study was conducted in accordance with the principles of the Declaration of Helsinki. This study was approved by the Research Ethics Committee (Approval Number: 54022451-050.05.04-11445).
Informed consent
Informed consent had been obtained from all patients before surgery and specimen sampling were conducted.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Akçay, A., Peker, A.A., Oran, Z. et al. Role of magnetic resonance imaging to differentiate between borderline and malignant serous epithelial ovarian tumors. Abdom Radiol 49, 229–236 (2024). https://doi.org/10.1007/s00261-023-04076-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-023-04076-9